Stepan Company Files 8-K for Regulation FD Disclosure
Ticker: SCL · Form: 8-K · Filed: Jan 27, 2025 · CIK: 94049
| Field | Detail |
|---|---|
| Company | Stepan Co (SCL) |
| Form Type | 8-K |
| Filed Date | Jan 27, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $1 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
Stepan Co filed an 8-K for a Reg FD disclosure on Jan 27, 2025. Details TBD.
AI Summary
Stepan Company filed an 8-K on January 27, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, dollar amounts, or dates beyond the filing date itself.
Why It Matters
This filing indicates Stepan Company is making a public disclosure under Regulation FD, which ensures all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial implications or significant new information.
Key Players & Entities
- Stepan Company (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- January 27, 2025 (date) — Date of Report
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that one is being made.
When was the earliest event reported in this filing?
The earliest event reported is January 27, 2025, which is also the date of the report.
What is Stepan Company's principal executive office address?
Stepan Company's principal executive offices are located at 1101 Skokie Boulevard, Suite 500, Northbrook, Illinois, 60062.
What is Stepan Company's telephone number?
Stepan Company's telephone number is 847 446-7500.
What is the SEC file number for Stepan Company?
The SEC file number for Stepan Company is 1-4462.
Filing Stats: 1,011 words · 4 min read · ~3 pages · Grade level 18.2 · Accepted 2025-01-27 06:01:31
Key Financial Figures
- $1 — nge on which registered Common Stock, $1 par value SCL The New York Stock Ex
Filing Documents
- scl-20250127.htm (8-K) — 44KB
- 0000950170-25-008978.txt ( ) — 156KB
- scl-20250127.xsd (EX-101.SCH) — 24KB
- scl-20250127_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. In connection with meetings and presentations at an industry conference beginning on January 27, 2025, Stepan Company (the "Company") provided an update on the construction of its new alkoxylation facility in Pasadena, Texas. Due to unforeseen delays, the Company now expects the startup of the facility to occur in the first quarter of 2025. The Company does not expect this change in the startup date to materially impact its first quarter results or otherwise materially impact the Company's business, financial condition or results of operations. The Company plans to provide additional detail regarding the expected startup of the facility during the Company's forthcoming fourth quarter and full year 2024 earnings call. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise stated in such filing.
Forward-Looking Statements
Forward-Looking Statements Certain information in this Current Report on Form 8-K consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K re
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STEPAN COMPANY Date: January 27, 2025 By: /s/ David G. Kabbes David G. Kabbes Vice President, General Counsel and Secretary